Hologic Ownership
| HOLX Stock | USD 65.23 0.22 0.34% |
Shares in Circulation | First Issued 1988-12-31 | Previous Quarter 236 M | Current Value 232.1 M | Avarage Shares Outstanding 156.1 M | Quarterly Volatility 106.6 M |
Hologic |
Hologic Stock Ownership Analysis
About 99.0% of the company shares are owned by institutional investors. The book value of Hologic was currently reported as 21.16. The company has Price/Earnings To Growth (PEG) ratio of 1.42. Hologic had not issued any dividends in recent years. The entity had 2:1 split on the 3rd of April 2008. Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for womens health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts. Hologic operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 6705 people. To learn more about Hologic call Stephen MacMillan at 508 263 2900 or check out https://www.hologic.com.Besides selling stocks to institutional investors, Hologic also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Hologic's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Hologic's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Hologic Quarterly Liabilities And Stockholders Equity |
|
Hologic Insider Trades History
Only 1.13% of Hologic are currently held by insiders. Unlike Hologic's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Hologic's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Hologic's insider trades
Hologic Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Hologic is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Hologic backward and forwards among themselves. Hologic's institutional investor refers to the entity that pools money to purchase Hologic's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Boston Partners Global Investors, Inc | 2024-12-31 | 3.6 M | Ameriprise Financial Inc | 2024-12-31 | 3.5 M | Northern Trust Corp | 2024-12-31 | 3.1 M | Macquarie Group Ltd | 2024-12-31 | 3 M | Bank Of America Corp | 2024-12-31 | 2.8 M | Hsbc Holdings Plc | 2024-12-31 | 2.8 M | Dimensional Fund Advisors, Inc. | 2024-12-31 | 2.6 M | Jpmorgan Chase & Co | 2024-09-30 | 2.6 M | Alliancebernstein L.p. | 2024-12-31 | 2.6 M | Vanguard Group Inc | 2024-12-31 | 26.9 M | Blackrock Inc | 2024-12-31 | 22.2 M |
Hologic Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Hologic insiders, such as employees or executives, is commonly permitted as long as it does not rely on Hologic's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Hologic insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Hologic's latest congressional trading
Congressional trading in companies like Hologic, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Hologic by those in governmental positions are based on the same information available to the general public.
Hologic Outstanding Bonds
Hologic issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Hologic uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Hologic bonds can be classified according to their maturity, which is the date when Hologic has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Hologic 4625 percent Corp BondUS436440AM32 | View | |
| HOLOGIC INC 325 Corp BondUS436440AP62 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Hologic Corporate Filings
| 14th of February 2025 Other Reports | ViewVerify | |
F4 | 12th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10Q | 6th of February 2025 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 5th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Hologic Stock Analysis
When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.